Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Link opens in a new tab
Search content at Maastricht University
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Defining Nano, Nanotechnology and Nanomedicine: Why Should it Matter?
P. Satalkar
*
, B.S. Elger
,
D. Shaw
*
Corresponding author for this work
Metamedica
CAPHRI - Health Inequities and Societal Participation
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Defining Nano, Nanotechnology and Nanomedicine: Why Should it Matter?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nanotechnology
100%
Nanomedicine
100%
Clinical Application
25%
Clinical Trials
12%
Europe
12%
North America
12%
General Public
12%
Translational Research
12%
Disease Diagnosis
12%
Diagnostic Modalities
12%
Health Care Costs
12%
Therapeutic Modalities
12%
Miscommunication
12%
Review Process
12%
Public Acceptance
12%
Potential Harm
12%
Translational Nanomedicine
12%
Honest Communication
12%
Common Interest
12%
Key Enabling Technologies
12%
Basic Science Research
12%
Regulatory Approval
12%
Transparent Communication
12%
Patented Drugs
12%
Medical Applications
12%
Nanotechnology Applications
12%
Ethical Review Process
12%
Fund Allocation
12%
Drug Regulatory
12%
Qualitative Interviews
12%
Diseases Therapeutic
12%
INIS
nanotechnology
100%
applications
50%
reviews
33%
diseases
16%
drugs
16%
risks
16%
cost
16%
allocations
16%
clinical trials
16%
europe
16%
patents
16%
north america
16%
nanostructures
16%
Medicine and Dentistry
Nanomedicine
100%
Health Care Cost
11%
Clinical Trial
11%
Translational Research
11%
Therapeutic Modality
11%
Diseases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Nanomedicine
100%
Clinical Trial
11%
Diseases
11%
Chemical Engineering
Nanomedicine
100%
Engineering
Health Care
11%